07:31 AM EDT, 10/27/2026 (MT Newswires) -- Thor Medical (TRMED.OL) secured a three-year contract from the UK's Medicines Discovery Catapult to deliver radium-224 and lead-212 isotopes. The deal will support the life science service's work to accelerate the development of radiopharmaceutical therapies based on the isotopes in the UK, the Norwegian high-purity isotope supplier said Tuesday. The initial shipments have already been made.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.